Growth suppression in children receiving acetazolamide with antiepileptic drugs

Pediatric Neurology

Volumn 15, Issue 4, 1996, Pages 323-326

  Futagi, Yasuyuki ^a   Otani, Kazumasa ^a   Abe, Jiro ^b  

^a RESEARCH INSTITUTE FOR MATERNAL AND CHILD HEALTH   (Japan)

^b Hyogo Prefectural Nishinomiya Hospital   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ACETAZOLAMIDE; ANTICONVULSIVE AGENT; CARBAMAZEPINE; CARBON DIOXIDE; CHLORIDE; PHENOBARBITAL; POTASSIUM; VALPROIC ACID; ZONISAMIDE;

ANTICONVULSANT THERAPY; ARTICLE; BODY HEIGHT; BODY WEIGHT; CHILD; CHILD GROWTH; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; EPILEPSY; FEMALE; GROWTH INHIBITION; HUMAN; MALE; METABOLIC ACIDOSIS; PRIORITY JOURNAL; SCORING SYSTEM;

ACETAZOLAMIDE; ACIDOSIS; ADOLESCENT; ANTICONVULSANTS; BODY HEIGHT; BODY WEIGHT; CHILD; CHILD, PRESCHOOL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG THERAPY, COMBINATION; DWARFISM; ELECTROLYTES; EPILEPSY; FEMALE; HUMANS; INFANT; MALE;

EID: 0030298437     PISSN: 08878994     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0887-8994(96)00228-7     Document Type: Article

References (23)

1. [1] Lombroso CT, Forxythe I. A long-term follow-up of acetazolamide (diamox) in the treatment of epilepsy. Epilepsia 1960;1:493-500.
2. [2] Oles KS, Penry JK, Cole DLW, Howard G. Use of acetazolamide as an adjunct to carbamazepine in refractory partial seizures. Epilepsia 1989;30:74-8.
3. [3] Forsythe WI, Owens JR, Toothill C. Effectiveness of acetazolamide in the treatment of carbamazepine-resistant epilepsy in children. Dev Med Child Neurol 1981;23:761-9.
4. [4] Bergstrom WH, Carzoli RF, Lombroso C, Davidson DT, Wallace WM. Observations on the metabolic and clinical effects of carbonic-anhydrase inhibitors in epileptics. Am J Dis Child 1952;84:771-2.
5. [5] Millichap JG. Anticonvulsant action of Diamox in children. Neurology 1956;6:552-9.
6. [6] Resor SR, Resor LD. Chronic acetazolamide monotherapy in the treatment of juvenile myoclonic epilepsy. Neurology 1990;40:1677-81.
7. [7] Roberts RJ. Diuretics. Drug therapy in infants: pharmacologic principles and clinical experience, 1st ed. Philadelphia: W.B. Saunders, 1984:228-33.
8. [8] Santos F, Chan JCM. Renal tubular acidosis in children. Am J Nephrol 1986;6:289-95.
9. [9] Suwa S, Tachibana K. Standard growth table for Japanese children in 1990. Tokyo: Sumitomo Pharmaceutical, 1992.
10. [10] Iwahara S. Statistics for education and psychology. Tokyo: Nihonbunkakagakusha, 1993:252-9.
11. [11] Millichap JG, Woodbury DM, Goodman LS. Mechanism of the anticonvulsant action of acetazolamide, a carbonic anhydrase inhibitor. J Pharmacol Exp Ther 1955;115:251-8.
12. [12] Anderson RE, Howard RA, Woodbury DM. Correlation between effects of acute acetazolamide administration to mice on electroshock seizure pattern, and on carbonic anhydrase activity in subcellular fractions of brain. Epilepsia 1986;27:504-9.
13. [13] Tattersall RB, Pyke DA. Growth in diabetic children. Studies in identical twins. Lancet 1973;7838:1105-9.
14. [14] Donckerwolcke R, Yang WN, Chan JCM. Growth failure in children with renal tubular acidosis. Semin Nephrol 1989;9:72-4.
15. [15] Kalhoff H, Manz F, Diekmann L, Kunz C, Sock GJ, Weisser F. Decreased growth rate of low-birth-weight infants with prolonged maximum renal acid stimulation. Acta Paediatr 1993;82:522-7.
16. [16] McSherry E. Acidosis and growth in nonuremic renal disease. Kidney Int 1978;14:349-54.
17. [17] Naeije R, Golstein J, Clumeck N, Meinhold H, Wenzel KW, Vanhaelst L. A low T3 syndrome in diabetic ketoacidosis. Clin Endocrinol 1978;8:467-72.
18. [18] Castells S. Thyroid function in juvenile diabetes. Pediatr Clin North Am 1984;31:623-34.
19. [19] Chan JCM. Renal tubular acidosis. J Pediatr 1983;102:327-40.
20. [20] Tahirović HF. Thyroid hormones changes in infants and children with metabolic acidosis. J Endocrinol Invest 1991;14:722-5.
21. [21] Heller I, Halevy J, Cohen S, Theodor E. Significant metabolic acidosis induced by acetazolamide. Arch Intern Med 1985;145:1815-7.
22. [22] De Marchi S, Cecchin E. Severe metabolic acidosis and disturbances of calcium metabolism induced by acetazolamide in patients on haemodialysis. Clin Sci 1990;78:295-302.
23. [23] Churchill E. Statistical considerations. In: Falkner F, ed. Human development. Philadelphia: W.B. Saunders, 1966:40-75.